Glucotrack Inc (GCTK)
0.4936 x 363 0.4950 x 20
Post-market by (Cboe BZX)
0.4899 -0.0270 (-5.22%) 02/14/25 [NASDAQ]
0.4936 x 363 0.4950 x 20
Post-market 0.4936 +0.0037 (+0.76%) 19:59 ET
for Fri, Feb 14th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 0 | 0 | 0 | 0 | 208 |
Gross Profit | N/A | N/A | N/A | N/A | 208 |
Operating Expenses | 7,104 | 4,432 | 4,040 | 3,132 | 3,714 |
Operating Income | -7,104 | -4,432 | -4,040 | -3,132 | -3,506 |
Other Income | 7 | -3 | -27 | 436 | -10 |
Pre-tax Income | -7,097 | -4,435 | -4,067 | -2,696 | -3,516 |
Net Income Continuous | -7,097 | -4,435 | -4,067 | -2,696 | -3,516 |
Net Income | $-7,097 | $-4,435 | $-4,067 | $-2,696 | $-3,516 |
EPS Basic Total Ops | -1.90 | -1.45 | -1.30 | -0.95 | -1.30 |
EPS Basic Continuous Ops | -1.71 | -1.43 | -1.32 | -0.89 | -1.48 |
EPS Diluted Total Ops | -1.90 | -1.45 | -1.30 | -0.95 | -1.30 |
EPS Diluted Continuous Ops | -1.71 | -1.43 | -1.32 | -0.89 | -1.48 |
EPS Diluted Before Non-Recurring Items | -38.00 | -29.00 | N/A | N/A | N/A |
EBITDA(a) | $-7,091 | $-4,409 | $-3,998 | $-3,085 | $-3,455 |